Raffles Medical Group Stock Net Income
| RAFLFDelisted Stock | USD 0.74 0.00 0.00% |
Raffles Medical Group fundamentals help investors to digest information that contributes to Raffles Medical's financial success or failures. It also enables traders to predict the movement of Raffles Pink Sheet. The fundamental analysis module provides a way to measure Raffles Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Raffles Medical pink sheet.
Raffles |
Raffles Medical Group Company Net Income Analysis
Raffles Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Raffles Medical Net Income | 84.17 M |
Most of Raffles Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Raffles Medical Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Raffles Medical Group reported net income of 84.17 M. This is 75.34% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The net income for all United States stocks is 85.26% higher than that of the company.
Raffles Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Raffles Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Raffles Medical could also be used in its relative valuation, which is a method of valuing Raffles Medical by comparing valuation metrics of similar companies.Raffles Medical is currently under evaluation in net income category among its peers.
Raffles Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0624 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 1.82 B | |||
| Shares Outstanding | 1.85 B | |||
| Shares Owned By Insiders | 55.30 % | |||
| Shares Owned By Institutions | 15.91 % | |||
| Price To Earning | 31.40 X | |||
| Price To Book | 2.25 X | |||
| Price To Sales | 2.49 X | |||
| Revenue | 723.79 M | |||
| Gross Profit | 193.55 M | |||
| EBITDA | 161.27 M | |||
| Net Income | 84.17 M | |||
| Cash And Equivalents | 289.07 M | |||
| Cash Per Share | 0.16 X | |||
| Total Debt | 77.91 M | |||
| Debt To Equity | 0.18 % | |||
| Current Ratio | 1.07 X | |||
| Book Value Per Share | 0.51 X | |||
| Cash Flow From Operations | 160.11 M | |||
| Earnings Per Share | 0.04 X | |||
| Number Of Employees | 2.7 K | |||
| Beta | 0.61 | |||
| Market Capitalization | 1.92 B | |||
| Total Asset | 1.55 B | |||
| Retained Earnings | 318 M | |||
| Working Capital | 32 M | |||
| Current Asset | 212 M | |||
| Current Liabilities | 180 M | |||
| Z Score | 14.4 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 1.55 B | |||
| Last Dividend Paid | 0.018 |
About Raffles Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Raffles Medical Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Raffles Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Raffles Medical Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Raffles Pink Sheet
If you are still planning to invest in Raffles Medical Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Raffles Medical's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |